Cellular dynamics in pig-to-human kidney xenotransplantation
“Early trials of porcine kidney xenotransplantation have been performed on brain-dead human recipients, but the [MORE]
Mouse genome rewriting and tailoring of three important disease loci
“Here we [NYU Grossman School of Medicine] describe ‘mammalian switching antibiotic [MORE]
From left, team members Qijun Liu of Boston University, Maria Eugenia Inda of MIT, and Miguel Jimenez of MIT pose [MORE]
Engineered bacteria deliver chemokines to alert the immune system to tumors
“Here, we [at Columbia University] engineer bacteria to intratumorally release [MORE]
Intestinal transgene delivery with native E. coli chassis allows persistent physiological change
“In this proof-of-concept study, we [gastroenterologists at the University [MORE]
History of Creating Genetically Humanized Mice
“Historically, genetic humanization of model organisms was achieved through one of two methods: random insertion [MORE]
Surgeons successfully transplanted a pig kidney to a human
“The surgical team, from NYU Langone Health, attached the pig kidney to [MORE]
Engineered organism could diagnose Crohn’s disease flareups
“In an important step toward the clinical application of synthetic biology, Rice University researchers [MORE]
Gene-editing tool “sneaks” DNA into cells without cuts
“Researchers [Wyss Institute] have created a new gene editing tool called Retron Library [MORE]
Synthetic cell growing and dividing
From the J. Craig Venter Institute and collaborators at NIST and MIT comes this: “For the [MORE]
Lab researcher
In order to engineer a virus that mimics SARS-CoV-2 without causing COVID-19’s severe symptoms, virologists at Washington University in [MORE]
Creating transgenic mice that express prion disease
Until now, researchers studying animal models of prion diseases have had to introduce a [MORE]
Genetically engineered phage therapy
A teenage girl developed an antibiotic-resistant infection following a lung transplant to treat cystic fibrosis. Her prospects [MORE]
Heat-sensitive genetic switch for T cell
Georgia Tech bioengineers have developed means to control T-cells activity in cancer therapy. They introduced a [MORE]